Exact Mass: 447.2311
Exact Mass Matches: 447.2311
Found 500 metabolites which its exact mass value is equals to given mass value 447.2311
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Palbociclib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Ronacaleret
2-(2H-Benzotriazol-2-yl)-4,6-bis(1-methyl-1-phenylethyl)phenol
(1S,3R,17S,19S)-3-Hydroxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.01,17 03,15 04,13 07,12 019,23]hexacosa-4,6,10,12,14-pentaene-24,26-dione
Thr Lys Ala Glu
C26H29N3O4_8H,10H-7a,12a-(Iminomethano)indolizino[6,7-h]pyrano[3,2-a]carbazole-8,16-dione, 3,6b,7,11,12,13,13a,14-octahydro-6b-hydroxy-3,3,14,14-tetramethyl-, (6bR,7aS,12aS,13aS)
(1S,3R,17S,19S)-3-hydroxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-4,6,10,12,14-pentaene-24,26-dione
Ala Ala Met Arg
Ala Ala Arg Met
Ala Cys Arg Val
Ala Cys Val Arg
Ala Glu Lys Thr
Ala Glu Thr Lys
Ala Ile Met Asn
Ala Ile Asn Met
Ala Lys Glu Thr
Ala Lys Thr Glu
Ala Leu Met Asn
Ala Leu Asn Met
Ala Met Ala Arg
Ala Met Ile Asn
Ala Met Leu Asn
Ala Met Asn Ile
Ala Met Asn Leu
Ala Met Gln Val
Ala Met Arg Ala
Ala Met Val Gln
Ala Asn Ile Met
Ala Asn Leu Met
Ala Asn Met Ile
Ala Asn Met Leu
Ala Gln Met Val
Ala Gln Val Met
Ala Arg Ala Met
Ala Arg Cys Val
Ala Arg Met Ala
Ala Arg Thr Thr
Ala Arg Val Cys
Ala Thr Glu Lys
Ala Thr Lys Glu
Ala Thr Arg Thr
Ala Thr Thr Arg
Ala Val Cys Arg
Ala Val Met Gln
Ala Val Gln Met
Ala Val Arg Cys
Cys Ala Arg Val
Cys Ala Val Arg
Cys Gly Ile Arg
Cys Gly Leu Arg
Cys Gly Arg Ile
Cys Gly Arg Leu
Cys Ile Gly Arg
Cys Ile Asn Val
Cys Ile Arg Gly
Cys Ile Val Asn
Cys Lys Pro Thr
Cys Lys Thr Pro
Cys Leu Gly Arg
Cys Leu Asn Val
Cys Leu Arg Gly
Cys Leu Val Asn
Cys Asn Ile Val
Cys Asn Leu Val
Cys Asn Val Ile
Cys Asn Val Leu
Cys Pro Lys Thr
Cys Pro Thr Lys
Cys Gln Val Val
Cys Arg Ala Val
Cys Arg Gly Ile
Cys Arg Gly Leu
Cys Arg Ile Gly
Cys Arg Leu Gly
Cys Arg Val Ala
Cys Thr Lys Pro
Cys Thr Pro Lys
Cys Val Ala Arg
Cys Val Ile Asn
Cys Val Leu Asn
Cys Val Asn Ile
Cys Val Asn Leu
Cys Val Gln Val
Cys Val Arg Ala
Cys Val Val Gln
Asp Lys Ser Val
Asp Lys Val Ser
Asp Ser Lys Val
Asp Ser Val Lys
Asp Val Lys Ser
Asp Val Ser Lys
Glu Ala Lys Thr
Glu Ala Thr Lys
Glu Lys Ala Thr
Glu Lys Thr Ala
Glu Thr Ala Lys
Glu Thr Lys Ala
Gly Cys Ile Arg
Gly Cys Leu Arg
Gly Cys Arg Ile
Gly Cys Arg Leu
Gly Ile Cys Arg
Gly Ile Met Gln
Gly Ile Gln Met
Gly Ile Arg Cys
Gly Leu Cys Arg
Gly Leu Met Gln
Gly Leu Gln Met
Gly Leu Arg Cys
Gly Met Ile Gln
Gly Met Leu Gln
Gly Met Gln Ile
Gly Met Gln Leu
Gly Gln Ile Met
Gly Gln Leu Met
Gly Gln Met Ile
Gly Gln Met Leu
Gly Arg Cys Ile
Gly Arg Cys Leu
Gly Arg Ile Cys
Gly Arg Leu Cys
Ile Ala Met Asn
Ile Ala Asn Met
Ile Cys Gly Arg
Ile Cys Asn Val
Ile Cys Arg Gly
Ile Cys Val Asn
Ile Gly Cys Arg
Ile Gly Met Gln
Ile Gly Gln Met
Ile Gly Arg Cys
Ile Met Ala Asn
Ile Met Gly Gln
Ile Met Asn Ala
Ile Met Gln Gly
Ile Asn Ala Met
Ile Asn Cys Val
Ile Asn Met Ala
Ile Asn Thr Thr
Ile Asn Val Cys
Ile Gln Gly Met
Ile Gln Met Gly
Ile Gln Ser Thr
Ile Gln Thr Ser
Ile Arg Cys Gly
Ile Arg Gly Cys
Ile Ser Gln Thr
Ile Ser Thr Gln
Ile Thr Asn Thr
Ile Thr Gln Ser
Ile Thr Ser Gln
Ile Thr Thr Asn
Ile Val Cys Asn
Ile Val Asn Cys
Lys Ala Glu Thr
Lys Ala Thr Glu
Lys Cys Pro Thr
Lys Cys Thr Pro
Lys Asp Ser Val
Lys Asp Val Ser
Lys Glu Ala Thr
Lys Glu Thr Ala
Lys Pro Cys Thr
Lys Pro Thr Cys
Lys Ser Asp Val
Lys Ser Val Asp
Lys Thr Ala Glu
Lys Thr Cys Pro
Lys Thr Glu Ala
Lys Thr Pro Cys
Lys Val Asp Ser
Lys Val Ser Asp
Leu Ala Met Asn
Leu Ala Asn Met
Leu Cys Gly Arg
Leu Cys Asn Val
Leu Cys Arg Gly
Leu Cys Val Asn
Leu Gly Cys Arg
Leu Gly Met Gln
Leu Gly Gln Met
Leu Gly Arg Cys
Leu Met Ala Asn
Leu Met Gly Gln
Leu Met Asn Ala
Leu Met Gln Gly
Leu Asn Ala Met
Leu Asn Cys Val
Leu Asn Met Ala
Leu Asn Thr Thr
Leu Asn Val Cys
Leu Gln Gly Met
Leu Gln Met Gly
Leu Gln Ser Thr
Leu Gln Thr Ser
Leu Arg Cys Gly
Leu Arg Gly Cys
Leu Ser Gln Thr
Leu Ser Thr Gln
Leu Thr Asn Thr
Leu Thr Gln Ser
Leu Thr Ser Gln
Leu Thr Thr Asn
Leu Val Cys Asn
Leu Val Asn Cys
Met Ala Ala Arg
Met Ala Ile Asn
Met Ala Leu Asn
Met Ala Asn Ile
Met Ala Asn Leu
Met Ala Gln Val
Met Ala Arg Ala
Met Ala Val Gln
Met Gly Ile Gln
Met Gly Leu Gln
Met Gly Gln Ile
Met Gly Gln Leu
Met Ile Ala Asn
Met Ile Gly Gln
Met Ile Asn Ala
Met Ile Gln Gly
Met Leu Ala Asn
Met Leu Gly Gln
Met Leu Asn Ala
Met Leu Gln Gly
Met Asn Ala Ile
Met Asn Ala Leu
Met Arg Ala Ala
Asn Ile Thr Thr
Asn Leu Thr Thr
Asn Thr Ile Thr
Asn Thr Leu Thr
Asn Thr Thr Ile
Asn Thr Thr Leu
Gln Ile Ser Thr
Gln Ile Thr Ser
Gln Leu Ser Thr
Gln Leu Thr Ser
Gln Ser Ile Thr
Gln Ser Leu Thr
Gln Ser Thr Ile
Gln Ser Thr Leu
Gln Thr Ile Ser
Gln Thr Leu Ser
Gln Thr Ser Ile
Gln Thr Ser Leu
Gln Thr Thr Val
Gln Thr Val Thr
Gln Val Thr Thr
Arg Ala Ala Met
Arg Ala Cys Val
Arg Ala Met Ala
Arg Ala Thr Thr
Arg Ala Val Cys
Arg Cys Ala Val
Arg Cys Gly Ile
Arg Cys Gly Leu
Arg Cys Ile Gly
Arg Cys Leu Gly
Arg Cys Val Ala
Arg Gly Cys Ile
Arg Gly Cys Leu
Arg Gly Ile Cys
Arg Gly Leu Cys
Arg Ile Cys Gly
Arg Ile Gly Cys
Arg Leu Cys Gly
Arg Leu Gly Cys
Arg Met Ala Ala
Arg Ser Ser Val
Arg Ser Val Ser
Arg Thr Ala Thr
Arg Thr Thr Ala
Arg Val Ala Cys
Arg Val Cys Ala
Arg Val Ser Ser
Ser Asp Lys Val
Ser Asp Val Lys
Ser Ile Gln Thr
Ser Ile Thr Gln
Ser Lys Asp Val
Ser Lys Val Asp
Ser Leu Gln Thr
Ser Leu Thr Gln
Ser Gln Ile Thr
Ser Gln Leu Thr
Ser Gln Thr Ile
Ser Gln Thr Leu
Ser Arg Ser Val
Ser Arg Val Ser
Ser Ser Arg Val
Ser Ser Val Arg
Ser Thr Ile Gln
Ser Thr Leu Gln
Ser Thr Gln Ile
Ser Thr Gln Leu
Ser Val Asp Lys
Ser Val Lys Asp
Ser Val Arg Ser
Ser Val Ser Arg
Thr Ala Glu Lys
Thr Ala Lys Glu
Thr Ala Arg Thr
Thr Ala Thr Arg
Thr Glu Ala Lys
Thr Glu Lys Ala
Thr Ile Asn Thr
Thr Ile Gln Ser
Thr Ile Ser Gln
Thr Ile Thr Asn
Thr Lys Glu Ala
Thr Leu Asn Thr
Thr Leu Gln Ser
Thr Leu Ser Gln
Thr Leu Thr Asn
Thr Asn Ile Thr
Thr Asn Leu Thr
Thr Asn Thr Ile
Thr Asn Thr Leu
Thr Gln Ile Ser
Thr Gln Leu Ser
Thr Gln Ser Ile
Thr Gln Ser Leu
Thr Gln Thr Val
Thr Gln Val Thr
Thr Arg Ala Thr
Thr Arg Thr Ala
Thr Ser Ile Gln
Thr Ser Leu Gln
Thr Ser Gln Ile
Thr Ser Gln Leu
Thr Thr Ala Arg
Thr Thr Ile Asn
Thr Thr Leu Asn
Thr Thr Asn Ile
Thr Thr Asn Leu
Thr Thr Gln Val
Thr Thr Arg Ala
Thr Thr Val Gln
Thr Val Gln Thr
Thr Val Thr Gln
Val Ala Cys Arg
Val Ala Met Gln
Val Ala Gln Met
Val Ala Arg Cys
Val Cys Ala Arg
Val Cys Ile Asn
Val Cys Leu Asn
Val Cys Asn Ile
Val Cys Asn Leu
Val Cys Gln Val
Val Cys Arg Ala
Val Cys Val Gln
Val Asp Lys Ser
Val Asp Ser Lys
Val Ile Cys Asn
Val Ile Asn Cys
Val Lys Asp Ser
Val Lys Ser Asp
Val Leu Cys Asn
Val Leu Asn Cys
Val Met Ala Gln
Val Met Gln Ala
Val Asn Cys Ile
Val Asn Cys Leu
Val Asn Ile Cys
Val Asn Leu Cys
Val Gln Ala Met
Val Gln Cys Val
Val Gln Met Ala
Val Gln Thr Thr
Val Gln Val Cys
Val Arg Ala Cys
Val Arg Cys Ala
Val Arg Ser Ser
Val Ser Asp Lys
Val Ser Lys Asp
Val Ser Arg Ser
Val Ser Ser Arg
Val Thr Gln Thr
Val Thr Thr Gln
Val Val Cys Gln
Val Val Gln Cys
Ronacaleret
C78281 - Agent Affecting Musculoskeletal System
(8R)-8-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]nonanoic acid
9-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]nonanoic acid
palbociclib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS